#news #medical #clinicalresearch #lifesciences #pharma #pharmiweb
Monocyte, Allergy, Antibody, Immune system, White blood cell, T helper cell
GB Sciences Begins Proof of Concept Studies with Michigan State University for the Treatment of Cytokine Release Syndrome
GB Sciences Begins Proof of Concept Studies with Michigan State University for the Treatment of Cytokine Release Syndrome
https://t.co/Tdsy6UAMZ4
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/nTfSzliVFi
OpenIf successful, data from this preclinical study would be used as part of the support for an Independent New Drug (IND)-filing with the US Food and Drug Administration (FDA) for the use of GBS' Cannabinoid Containing Complex Mixtures (CCCM™) to treat the potentially-fatal Cytokine ...
GB Sciences Begins Proof of Concept Studies with Michigan State University for the Treatment of Cytokine Release Syndrome
https://t.co/Tdsy6UAMZ4
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/nTfSzliVFi
OpenGB Sciences Begins Proof of Concept Studies with Michigan State University for the Treatment of Cytokine Release Syndrome
If successful, data from this preclinical study would be used as part of the support for an Independent New Drug (IND)-filing with the US Food and Drug Administration (FDA) for the use of ...
We are sorry, we could not find the related article
If you are curious about Biotech Essentials, the Influencers Review and Career and Jobs
Please click on:
Or signup to our newsletters
Partner Therapeutics Initiates Patient Enrollment in U.S. Clinical Trial Evaluating Leukine® (rhuGM-CSF, sargramostim) in COVID-19 Patients
LEXINGTON, Mass., Aug. 25, 2020 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced today that the first patient has been enrolled in the ...
Immune-Activating Gene Therapy for Gliobastoma
The results of an early trial in 31 brain cancer patients finds immune activity boosted in the tumor, and possibly longer survival.
India clears a psoriasis drug for COVID-19, and a tiny US biotech's shares soar
An emergency approval for Biocon's drug Alzumab in India could lead its U.S. partner, Equillium, to start broader trials in coronavirus disease.
Kids mount a COVID-19 immune response without detection of the SARSCoV- 2 virus
Children in an Australian family developed a COVID-19 immune response after chronic exposure to the SARS-CoV-2 virus from their parents, a new case report has found.
Cytokine Storm
Review Article from The New England Journal of Medicine — Cytokine Storm
Cytokine release syndrome in severe COVID-19
Lessons from arthritis and cell therapy in cancer patients point to therapy for severe disease
Mom’s immune system and microbiome may help predict premature birth
Analyzing patients’ immune systems, microbiomes and more, researchers find signals to pinpoint and halt premature labor.
Review of 4 cell therapy types under study for COVID-19
This is a post by Mina Kim, an intern for The Niche blog, about the main types of cellular therapies being studied clinically for COVID-19.
Cannabis and the Immune System: A Complex Balancing Act
A new wave of research points toward cannabinoids having an adaptive, immunomodulating effect, rather than just suppressing immune activity.
Gut cells sound the alarm when parasites invade
To effectively combat an infection, the body first has to sense it's been invaded, then the affected tissue must send out signals to corral resources to fight the intruder. Knowing more ...
Does cannabis help or hurt the immune system?
Some studies suggest cannabis can help the immune system, while others imply the plant can suppress it. Learn more about the current research on how cannabis effects the immune system.
Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement
Click on the article title to read more.
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Xyphos Biosciences, Inc. (CEO: James Knighton,...
'Magic Soup': How Intermittent Fasting May Enhance The Immune System
New studies on mice and humans offer a few explanations for how fasting might temporarily confer certain health benefits.
Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
These findings should not be considered clinical advice but are being shared to assist the public health response to COVID-19
Cancer Treatment Takes Aim at Tauopathy
In one effort, three pharma companies tried, and failed, to recreate the amyloid-clearing effects of antibodies targeting the programmed cell death receptor PD-1, as was first reported by ...